MedPath

A Study on the relation between platelets and liver enzymes with Liver fibroscan to find the severity of liver disease in patients who have non alcoholic fatty liver disease

Not Applicable
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2024/08/071952
Lead Sponsor
Department of general medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients who are diagnosed having NAFLD and NASH , undergoing fibrous scan in kasturba hospital Manipal

Exclusion Criteria

Hepatitis B, hepatitis C, auto immune hepatitis, ITP ,history of herbal medication use, history of inherited jaundice

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Find out association of APRI,FIB-4,AST/ALT ration with fibroscan and using it for assessing hepatic fibrosisTimepoint: Cross sectional study
Secondary Outcome Measures
NameTimeMethod
To find which score among these have better association with fibroscanTimepoint: Cross sectional study
© Copyright 2025. All Rights Reserved by MedPath